| Conference Presentations |
| State Licensure Overview - "What's Going On Out There?" Patients, Problems, Drug Use Trends | Arvida Wanner, MS |
| Treatment of Opiate Dependence: Clinical Needs and Care Coordination Opportunities to Enhance Patient Safety | James Schuster, MD, MBA |
Patient Respect, Patient Advocacy, Hedonic Tone and Destitution
-Tony Stile.PPT -Edwin Salsitz.PPT | Sabato A. (Tony) Stile, MD
Edwin A. Salsitz, MD, FASAM |
| Opioid Addiction Medication Assisted Treatment: Part 1 - Clinical Pharmacology, Patient Assessment, Treatment Protocols, Patient Monitoring |
Trusandra Taylor, MD, FASAM, MPH
Charles Morgan, MD, FASAM, FAAFP |
Opioid Addiction Medication Assisted Treatment: Part 2 - Drug Interactions, Special Populations, Co-morbidity, Risk Management/Liability
-Trusandra Taylor1.PPT -Trusandra Taylor2.PPT | Laura McNicholas, MD, PhD
Trusandra Taylor, MD, FASAM, MPH |
| Psychiatric Aspects of MMT: Integrating Medical Model with Recovery | Fred Baurer, MD |
Buprenorphine Treatment Induction/Stabilization Update/Diversion
-Adam Gordon.PPT -James Schuster.PPT | Adam J. Gordon, MD, MPH, FACP
Laura McNicholas, MD, PhD
James Schuster, MD, MBA |
| Reference Materials |
| TIP 40 - Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction - A Treatment Improvement Protocol | SAMHSA/CSAT |
| TIP 43 - Medication-Assisted Treatment for Opioid Addiction and Opioid Treatment Programs - A Treatment Improvement Protocol | SAMHSA/CSAT |
| Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy | Annals of Internal Medicine
Daniel P. Alford, MD, MPH
Peggy Compton, RN, PhD
Jeffrey H. Samet, MD, MA, MPH |
| Methadone Hydrochloride Tablets, USP Black Box | Cebert Pharmaceuticals, Inc. |
| Dolophine Hydrochloride Tablets Black Box | Roxane Laboratories, Inc. |
| Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death | European Heart Journal
M. L. De Bruin
M. Pettersson
R. H. B. Meyboom
A. W. Hoes
H. G. M. Leufkens |
| When "Enough" Is Not Enough: New Perspectives on Optimal Methadone Maintenance Dose | Stewart B. Leavitt, PhD
Marc Shinderman, MD
Sarz Maxwell, MD
Chin B. Eap, PhD
Philip Paris, MD |
| Methadone Dosing & Safety in the Treatment of Opioid Addiction | Addiction Treatment Forum
Stewart B. Leavitt, PhD, AT Forum |
| Summary Report of the Meeting: Methadone Mortality - A Reassessment | U. S. Department of Health and Human Services, SAMHSA/CSAT |
| Guidelines for the Accreditation of Opioid Treatment Programs | SAMHSA |
| Practice Pointers - Safety Starting Methadone in MMT | Addiction Treatment Forum |
| The pharmacokinetics of methadone in healthy subjects and opiate users | K. Wolff
A. Rostami-Hodjegan
S. Shires
A. W. M. Hay
M. Feely
R. Calvert
D. Raistrick
Geoffrey. T. Tucker |
| Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes | Amin Rostami-Hodjegan
Kim Wolff
Alastair W. M. Hay
Duncan Raistrick
Robert Calvert
Geoffrey T. Tucker |
| Prevalence and Characteristics of Chronic Pain Among Chemically Dependent Patients in Methadone Maintenance and Residential Treatment Facilities | JAMA
Andrew Rosenblum, PhD
Herman Joseph, PhD
Chunki Fong, MS
Steven Kipnis, MD
Charles Cleland, PhD
Russell K. Portenoy, MD |
| Protocol for Informing Patients of Serious Events or Incidents | |
| Interindividual Variability of the Clinical Pharmacokinetics of Methadone. Implications for the Treatment of Opioid Dependence | Chin B. Eap
Thierry Buclin
Pierre Baumann |
